EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats

Alla Khodorova, Shiping Zou, Ke Ren, Ronald Dubner, Gudarz Davar, Gary Strichartz

The Open Pain Journal · 2009

DOI: 10.2174/1876386300902010030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Pain Journal, 2009. Verfasst von Alla Khodorova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Injection of endothelin-1 (ET-1) into the plantar rat hindpaw causes acute pain at high concentrations and tactile sensitization at low concentrations. The pro-nociceptive actions are driven through ETA receptors for both levels of [ET-1], but the ETB receptors are only pro-nociceptive for allodynia from low [ET-1] and anti-nociceptive for pain from high [ET-1]. The goal of the present work was to discriminate the roles of the ET receptors in the acute hyperalgesia from inflammation by complete Freund’s adjuvant (CFA, 20 mg/paw) into the rat hindpaw. Selective antagonists were injected l0 min before and then together with CFA. An ETA receptor antagonist, BQ-123, reduced CFA-induced thermal hyperalgesia (by up to 50%), as did an ETB receptor antagonist, BQ-788 (by up to 66%). BQ-123 and BQ-788 also delayed the onset (by 1.5 – 2 h) but insignificantly reduced the maximum degree of CFA-induced allodynia (~10%). Surprisingly, an ETB receptor agonist, IRL-1620, also reduced maximum thermal hyperalgesia induced by CFA, suppressed peak allodynia and delayed its occurrence by ~ 3 h. The latter actions of IRL-1620 were reversed by coadministration of BQ-788, naloxone hydrochloride and the peripherally restricted opiate receptor antagonist naloxone methiodide, and by antiserum against β-endorphin. These findings demonstrate an important role for endogenous ET-1 in acute inflammatory pain and a dual action of ETB receptors, including a pro-algesic action along with the important activation of a local analgesic pathway, implying that at least two different ETB receptors contribute to modulation of inflammatory pain.

Autor:innen und Institutionen

  • Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Förderung

  • NIDCR NIH HHS

Zitieren

APA

Khodorova, A., Zou, S., Ren, K., Dubner, R., Davar, G., & Strichartz, G. (2009). Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats. The Open Pain Journal. https://doi.org/10.2174/1876386300902010030

Vancouver

Khodorova A, Zou S, Ren K, Dubner R, Davar G, Strichartz G. Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats. The Open Pain Journal. 2009. doi:10.2174/1876386300902010030

BibTeX
@article{Khodorova2009,
  author = {Khodorova, Alla and Zou, Shiping and Ren, Ke and Dubner, Ronald and Davar, Gudarz and Strichartz, Gary},
  title = {Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats},
  journal = {The Open Pain Journal},
  year = {2009},
  doi = {10.2174/1876386300902010030}
}
Kostenlos starten →